Fig 1: A Comparison of serum NAMPT levels between NONFH patients and healthy controls. B Comparisons of serum NAMPT levels among different ARCO stages. C Comparisons of serum NAMPT levels among alcohol induced, steroid-induced and idiopathic NONFH. D Comparison of serum NAMPT levels between unilateral and bilateral NONFH
Fig 2: A Correlation of serum NAMPT levels with ARCO stages. B Correlation of serum NAMPT levels with HHS. C Correlation of serum NAMPT levels with VAS
Fig 3: A ROC curve analysis of serum NAMPT levels with regard to healthy controls vs NONFH cases. B ROC curve analysis of serum NAMPT levels with regard to ARCO 3 vs ARCO 4. C ROC curve analysis of serum NAMPT levels with regard to ARCO 2 vs ARCO 3
Fig 4: Changes in adipokines throughout the intervention. (A) Adiponectin; (B) Leptin; (C) Resistin; (D) Omentin; (E) Vaspin; (F) Visfatin; (G) Apelin; (H) Retinol binding protein 4 (RBP-4); (I) Chemerin; (J) Semaphorin-3c. n = 11 per group, error bars represent a 95% confidence interval (CI). * Significantly different from pre-test; # Significantly different than CG; ^ Significantly different than TG; € Significantly different than SG.
Supplier Page from CUSABIO Technology LLC for Human visfatin ELISA Kit